Copertina

Tratamiento en co-infección HIV-HCV y HBV-HCV

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Alejandro C Jmelnitzky
Natura:	Artículo científico
Lingua:	es
Pubblicazione:	Sociedad Argentina de Gastroenterología 2005
Soggetti:	Medicina
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Coinfección HBV-HCV y HIV-HCV
di: Fernando Bessone
Pubblicazione: (2005)

HBV And HCV Molecular Evolution
di: FLOR H. PUJOL
Pubblicazione: (2007)

Animal models for HCV and HBV studies
di: ISABELLE CHEMIN
Pubblicazione: (2007)

Tratamiento de la infección HCV en el cirrótico
di: Omar Galdame
Pubblicazione: (2005)

HCV genotype distribution among HIV co-infected individuals in Argentina: Relationship with host and viral factors
di: Jorge F Quarleri
Pubblicazione: (2007)

HCV and HCC molecular epidemiology
di: FLOR H. PUJOL
Pubblicazione: (2007)

HBV, HCV and HIV among inmates in Latin America and the Caribbean: A systematic review and meta‐analysis
di: Mariana Cavalheiro Magri, et al.
Pubblicazione: (2024)

Oral lichen planus and HCV infection
di: Jefferson R. Tenório
Pubblicazione: (2020)

Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV
di: Jeffrey V. Lazarus, et al.
Pubblicazione: (2025)

HCV‐HIV co‐infection in people who inject drugs: Barriers to treatment and cure of HCV infection in the era of DAAs, a prospective study in Athens, Greece
di: Dimitris Basoulis, et al.
Pubblicazione: (2024)

Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV / HBV Coinfected Patients in Guizhou, China
di: Mei Wang, et al.
Pubblicazione: (2025)

Development of Pentaplex Reverse Transcription Droplet Digital PCR Assay for Simultaneous Detection and Absolute Quantification of HIV‐1, HIV‐2, HCV, and HBV With Internal Control
di: Soo Yeon Lim, et al.
Pubblicazione: (2026)

Resolved HBV Infection Is Not Associated With Liver‐Related Outcomes in Survival Analysis of Caucasians After HCV Cure
di: Laura Muana Wilhelm, et al.
Pubblicazione: (2026)

Disruption of Signalling Pathways Induced by HBV HBx, HCV Core, and EBV LMP1 in Gastric Cancer
di: Mengli Gao, et al.
Pubblicazione: (2026)

Frequency of pregnant HBV / HCV carriers and status of their internal medicine consultation: A nationwide survey in Japan
di: Manabu Ogoyama, et al.
Pubblicazione: (2025)

Strategic Approach to Enhancing Diagnostic Precision: Optimizing Panel Size for HBV and HCV Viral Load Monitoring Kits
di: Gauri Misra, et al.
Pubblicazione: (2025)

Early Read‐Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia
di: Jessie Torgersen, et al.
Pubblicazione: (2025)

Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
di: Cintia Cevallos, et al.
Pubblicazione: (2024)

A Mathematical Framework for the Transmission Dynamics and Optimal Control of HCV‐HIV Coinfection and Superinfection
di: Burhanuddin Safi, et al.
Pubblicazione: (2026)

Co-infecção por HIV/HCV em hospital universitário de Recife, Brasil
di: Flávia Helena Pontes de Carvalho
Pubblicazione: (2009)

Epidemiological Trends and CD4+T Cell Recovery in HIV‐1 Patients With HCV/HBV Co‐Infection: A Retrospective Cohort Study in Southwest China (2003–2024)
di: Xianwu Pang, et al.
Pubblicazione: (2025)

Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre‐exposure prophylaxis in Taiwan: a modelling study
di: Huei‐Jiuan Wu, et al.
Pubblicazione: (2024)

HCV Cure: To Bridge the Gaps in the Care Continuum
di: Stanislas Pol, et al.
Pubblicazione: (2026)

Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: The fat redistribution and metabolic change in HIV infection (FRAM) study
di: Reingold J.S., et al.
Pubblicazione: (2008)

Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation
di: Kuo‐Cheng Wu, et al.
Pubblicazione: (2024)

Infección por el virus de la hepatitis C (HCV) en pacientes hemodializados seronegativos para anticuerpos anti-HCV
di: María Zulay Sulbarán
Pubblicazione: (2015)

HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)
di: Minyang Xiao, et al.
Pubblicazione: (2025)

Letter: ‘Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation’
di: You‐Jian Xu, et al.
Pubblicazione: (2024)

Prevalence of HCV infection in Europe in the DAA era: Review
di: Roberta D'Ambrosio, et al.
Pubblicazione: (2024)

Policy Learning with Observational Data: The Case of Hepatitis C Treatment for HIV/HCV Co-Infected Patients
di: Langevin, Raphaël
Pubblicazione: (2026)

Letter: Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply
di: Kuo‐Cheng Wu, et al.
Pubblicazione: (2024)

Longitudinal Changes in Immune Biomarkers Following Direct‐Acting Antiviral Therapy in HIV/HCV‐Coinfected Individuals in Indonesia
di: Evy Yunihastuti, et al.
Pubblicazione: (2025)

A systematic PCR record‐based re‐call of HCV‐RNA‐positive people enables re‐linkage to care and HCV elimination in Austria — The ELIMINATE project
di: Lorenz Balcar, et al.
Pubblicazione: (2024)

HCV prevalence and phylogenetic characteristics in a cross‐sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination
di: Mateu‐Gelabert Pedro, et al.
Pubblicazione: (2024)

Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia
di: Joselyn Pang, et al.
Pubblicazione: (2025)

HCV Elimination Strategies for Maximum Effectiveness, Tailored to National and Regional Circumstances
di: Ken Sato
Pubblicazione: (2025)

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action
di: Carolin Zitzmann, et al.
Pubblicazione: (2026)

Analysis of a Mathematical Model on the Dynamics of TB–HCV Coinfection With Medication
di: Kizito Mohammed, et al.
Pubblicazione: (2026)

Prevalência da soropositividade do anti-HCV em pacientes dialisados
di: Marcia Gomes
Pubblicazione: (2006)

Determinación de la prevalencia de hepatitis C mediante la prueba rápida BIOLINE HCV en una población de alto riesgo
di: Julián David Martínez
Pubblicazione: (2015)